These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37867630)

  • 1. Prediabetes is Associated with Worse Long-Term Outcomes in Young Patients with Acute Coronary Syndrome.
    Xu R; Wang C; Lang J; Wu J; Hu Y; Wang T; Zhang J; Cong H; Wang L
    Diabetes Metab Syndr Obes; 2023; 16():3213-3222. PubMed ID: 37867630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prediabetes on long-term cardiovascular outcomes in patients with myocardial infarction with nonobstructive coronary arteries.
    Gao S; Ma W; Huang S; Lin X; Yu M
    Diabetol Metab Syndr; 2021 Sep; 13(1):103. PubMed ID: 34560905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study.
    Farhan S; Redfors B; Maehara A; McAndrew T; Ben-Yehuda O; De Bruyne B; Mehran R; Giustino G; Kirtane AJ; Serruys PW; Mintz GS; Stone GW
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):733-741. PubMed ID: 29055637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary intervention.
    Wang H; Song Y; Tang X; Xu J; Jiang P; Jiang L; Gao Z; Chen J; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J; Gao L
    Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):644-651. PubMed ID: 32143897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
    Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Value of Free Triiodothyronine in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Yang ZQ; Ma XT; Shao QY; Li QX; Wang YF; Liang J; Shen H; Liu XL; Shi DM; Zhou YJ; Fang Z; Wang ZJ
    Rev Cardiovasc Med; 2022 Jul; 23(7):230. PubMed ID: 39076896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HbA1c-based rather than fasting plasma glucose-based definitions of prediabetes identifies high-risk patients with angiographic coronary intermediate lesions: a prospective cohort study.
    Song C; Yuan S; Cui K; Cai Z; Zhang R; He J; Qiao Z; Bian X; Wu S; Wang H; Shi B; Lin Z; Fu R; Wang C; Liu Q; Jia L; Dong Q; Dou K
    Cardiovasc Diabetol; 2023 Mar; 22(1):68. PubMed ID: 36966299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis.
    Zhao L; Zhu W; Zhang X; He D; Guo C
    BMC Cardiovasc Disord; 2017 Jan; 17(1):16. PubMed ID: 28061808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Curr Vasc Pharmacol; 2021; 19(1):91-101. PubMed ID: 32183677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of diabetes mellitus on 2-year clinical outcomes following PCI with second-generation drug-eluting stents; Landmark analysis findings from patient registry: Pooled analysis of the Korean multicenter drug-eluting stent registry.
    Lee CH; Choi SW; Jun SW; Hwang J; Kim IC; Cho YK; Park HS; Yoon HJ; Kim H; Nam CW; Han S; Kim KB; Hur SH
    PLoS One; 2020; 15(6):e0234362. PubMed ID: 32520973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention (HbA1c < 6.5% at 2 years) in type 2 diabetes mellitus combined with acute coronary syndrome: a 5-years follow-up study.
    Yang T; Fu P; Chen J; Fu X; Xu C; Liu X; Niu T
    Curr Med Res Opin; 2021 Sep; 37(9):1517-1528. PubMed ID: 34166166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.
    Wei CC; Shyu KG; Cheng JJ; Lo HM; Chiu CZ
    Acta Cardiol Sin; 2016 Jan; 32(1):31-8. PubMed ID: 27171367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prognostic ability of serum uric acid for elderly acute coronary syndrome patients with diabetes mellitus: a prospective cohort study.
    Jiao Y; Wang J; Yang X; Shen M; Xue H; Guo J; Dong W; Chen Y; Xi Q; Fu Z
    J Zhejiang Univ Sci B; 2021 Oct; 22(10):856-865. PubMed ID: 34636188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet treatment in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: a GReek AntiPlatElet registry substudy.
    Hamilos M; Petousis S; Xanthopoulou I; Goudevenos J; Kanakakis J; Sitafidis G; Vavouranakis M; Skalidis E; Kochiadakis G; Lekakis J; Vardas PE; Alexopoulos D
    Coron Artery Dis; 2018 Jan; 29(1):53-59. PubMed ID: 28834792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between lipoprotein(a) and revascularization after percutaneous coronary intervention in type 2 diabetes mellitus patients with acute coronary syndrome.
    Hao Y; Yang Y; Wang Y; Li J
    Curr Med Res Opin; 2022 Oct; 38(10):1663-1672. PubMed ID: 35575139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
    Åkerblom A; Wojdyla D; Steg PG; Wallentin L; James SK; Budaj A; Katus HA; Himmelmann A; Huber K; Siegbahn A; Storey RF; Becker RC;
    J Thromb Thrombolysis; 2019 Nov; 48(4):563-569. PubMed ID: 31512201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional Risk Index Improves the GRACE Score Prediction of Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Ma XT; Shao QY; Li QX; Yang ZQ; Han KN; Liang J; Shen H; Liu XL; Zhou YJ; Wang ZJ
    Front Cardiovasc Med; 2021; 8():773200. PubMed ID: 34977188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.